SectorBiological Technology
Established Date12/01/1994
Listing Date02/08/2019
ExchangeNASDAQ Stock Exchange
Full-time Employees17
Fiscal Year Ends31/12
Security TypeCommon stock
Office address320 Soquel Way, Sunnyvale, California 94085
Business
IntroductionBiocardia, Inc., was incorporated in Delaware on January 12, 1994. The company is a clinical-stage company developing cells and cell-derived therapies for cardiovascular and pulmonary diseases. Its CardiAMP autologous mononuclear cell therapy platform is advancing for ischemic heart failure and refractory angina, while its allogeneic mesenchymal stem cell therapy platform is being developed for ischemic inflammatory heart failure.
